⌘K

Login Start Free

Home/Filings/4/0001415889-25-021351

4//SEC Filing

Howe Jolanda 4

Accession 0001415889-25-021351

CIK 0001759425other

View on SEC.gov Company Profile

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 4:50 PM ET

Size

8.5 KB

Accession

0001415889-25-021351

Insider Transaction Report

Form 4

Period: 2025-08-07

Mirum Pharmaceuticals, Inc.MIRM

SVP, GLOBAL CONTROLLER

Transactions

Exercise/Conversion
Common Stock
2025-08-07$6.27/sh+10,000$62,700→ 12,426 total
Sale
Common Stock
2025-08-07$58.00/sh−10,000$580,000→ 2,426 total
Exercise/Conversion
Employee Stock Option (right to buy)
2025-08-07−10,000→ 40,000 total
Exercise: $6.27Exp: 2029-05-13→ Common Stock (10,000 underlying)

Footnotes (2)

[F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024.
[F2]The stock option is fully vested.

Documents

1 file

4
form4-08082025_080836.xmlPrimary

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1

filerCIK 0001974200

Filing Metadata

Form type: 4
Filed: Aug 7, 8:00 PM ET
Accepted: Aug 8, 4:50 PM ET
Size: 8.5 KB

View on SEC.gov